In this free webinar, learn about the benefits of moving beyond traditional site selection models by incorporating patient-centric intelligence into early landscapeIn this free webinar, learn about the benefits of moving beyond traditional site selection models by incorporating patient-centric intelligence into early landscape

Site Selection Solutions Using Patient Insights for Rare Disease Trials, Upcoming Webinar Hosted by Xtalks

2026/01/28 21:47
3 min read

In this free webinar, learn about the benefits of moving beyond traditional site selection models by incorporating patient-centric intelligence into early landscape analysis. Attendees will gain insight into applying a three-pillar, bottom-up approach that combines data intelligence, peer-level investigator outreach and patient organization engagement. The featured speakers will discuss how to identify the right sites and investigators earlier by understanding real-world treatment patterns and the patient journey. Attendees will learn how to improve enrollment feasibility and timelines while supporting more ethical and sustainable rare disease trial designs. The speakers will share real-world case studies demonstrating how patient-informed landscape analysis leads to better trial outcomes.

TORONTO, Jan. 28, 2026 /PRNewswire/ — In rare disease clinical trials, a comprehensive landscape analysis is essential for identifying the right sites, investigators and patient populations to ensure successful enrollment and retention. Traditional approaches rely heavily on published literature and academic networks as well as historical data from past clinical trials, often overlooking critical insights from local treatment patterns and patient communities. This gap can lead to missed opportunities, inaccurate estimation of enrollment potential and prolonged study timelines. This webinar demonstrates how patient-informed landscape analysis can strengthen site-selection decisions, and registration is now open.

To optimize site selection and recruitment for rare disease studies, it is crucial to conduct a systematic assessment of the existing research, development and market environment within the specific indication of interest. Implementing a three-pillar assessment approach that integrates data intelligence, medic-to-medic outreach and patient advocacy engagement supports more informed site-selection decisions earlier in the planning process.

In this webinar, the featured speakers will share practical insights from a landscape analysis approach and demonstrate why early investment in patient-centric intelligence leads to more feasible, ethical and successful rare disease trials.

Topics will include:

  • Leveraging comprehensive data sources to understand the competitive landscape, epidemiology, centers of excellence and historical recruitment performance
  • Conducting structured peer-level conversations with key opinion leaders and investigators to assess scientific interest, patient availability, recruitment potential and protocol feasibility
  • Building relationships with patient organizations to understand the patient journey and uncover site opportunities
  • Sharing of real-world case studies to showcase the value of strategic landscape analysis

Register for this webinar to learn how site selection improves when landscape analysis incorporates patient communities, real-world treatment patterns and site readiness signals.

Join experts from Ergomed Clinical Research, Paula Orandash, Director, Patient Engagement; and Benjamen Varsano, Director, Operational Strategy/Office Director, for the live webinar on Friday, February 20, 2026, at 10am EST (4pm CET/EU-Central).

For more information, or to register for this event, visit Site Selection Solutions Using Patient Insights for Rare Disease Trials.

ABOUT XTALKS

Xtalks — The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.

Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what’s next.

To learn more about Xtalks, visit www.xtalks.com

For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/

Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: [email protected]

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/site-selection-solutions-using-patient-insights-for-rare-disease-trials-upcoming-webinar-hosted-by-xtalks-302672076.html

SOURCE Xtalks

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags:

You May Also Like

The Arweave network has not produced a block for over 24 hours.

The Arweave network has not produced a block for over 24 hours.

PANews reported on February 7th that, according to Arweave Explorer data, the Arweave (AR) network has not produced a new block for over 24 hours. The last recorded
Share
PANews2026/02/07 14:49
HOT MOMENTS: FOMC Statement Released Following the Fed Interest Rate Decision – Here Are All the Details of the Full Text

HOT MOMENTS: FOMC Statement Released Following the Fed Interest Rate Decision – Here Are All the Details of the Full Text

The post HOT MOMENTS: FOMC Statement Released Following the Fed Interest Rate Decision – Here Are All the Details of the Full Text appeared on BitcoinEthereumNews.com. The Fed has resumed interest rate cuts after a nine-month hiatus, lowering the federal funds rate by 25 basis points to a range of 4% to 4.25%. According to the “dot plot” projection reflected in the decision text, two additional interest rate cuts are envisaged in 2025. While 9 out of 19 officials expected two more interest rate cuts this year, 2 predicted a single cut, and 6 predicted no additional cuts. Newly appointed Fed Board member Stephen I. Miran dissented from the decision, voting for a stronger 50 basis point cut. The decision noted that economic growth slowed in the first half of the year, employment growth slowed, and the unemployment rate rose slightly. It also noted that inflation had begun to rise but remained high. While reiterating that it maintains its long-term targets of maximum employment and 2% inflation, the Fed noted that uncertainties regarding the economic outlook remain high. The statement read, “The Committee assesses that downside risks to employment have increased, in line with the balance of risks.” The statement stated that interest rate policy will be reshaped in the coming period, taking into account future data, the economic outlook, and the balance of risks. It also noted that the reduction in holdings of Treasury bonds, corporate debt instruments, and mortgage-backed securities will continue. The resolution was supported by Fed Chair Jerome Powell, Vice Chair John C. Williams, and board members Michael S. Barr, Michelle W. Bowman, Susan M. Collins, Lisa D. Cook, Austan D. Goolsbee, Philip N. Jefferson, Alberto G. Musalem, Jeffrey R. Schmid, and Christopher J. Waller. *This is not investment advice. Follow our Telegram and Twitter account now for exclusive news, analytics and on-chain data! Source: https://en.bitcoinsistemi.com/hot-moments-fomc-statement-released-following-the-fed-interest-rate-decision-here-are-all-the-details-of-the-full-text/
Share
BitcoinEthereumNews2025/09/18 14:18
XRP recovers 12% in marketwide price rebound

XRP recovers 12% in marketwide price rebound

The post XRP recovers 12% in marketwide price rebound appeared on BitcoinEthereumNews.com. Crypto markets staged an impressive recovery on Friday, but XRP outpaced
Share
BitcoinEthereumNews2026/02/07 15:31